Full Name
Sundar, R.
Main Affiliation
 
 
Email
mdcragh@nus.edu.sg
 
Other emails
 

Publications

Results 1-11 of 11 (Search time: 0.015 seconds).

Issue DateTitleAuthor(s)
115-May-2021"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer ChemotherapyAn, Omer ; Song, Yangyang ; Ke, Xinyu; So, Jimmy Bok-Yan ; Sundar, Raghav ; Yang, Henry ; Rha, Sun Young; Lee, Ming Hui ; Tay, Su Ting ; Ong, Xuewen ; Tan, Angie Lay Keng ; Ng, Matthew Chau Hsien ; Tantoso, Erwin; Chen, Leilei ; Tan, Patrick ; Yong, Wei Peng 
22018A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancerSundar, R ; Rha, S.Y; Yamaue, H; Katsuda, M; Kono, K ; Kim, H.S; Kim, C; Mimura, K; Kua, L.-F ; Yong, W.P 
32020A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursAng, Y.L.E.; Ho, G.F.; Soo, R.A. ; Sundar, R. ; Tan, S.H.; Yong, W.P. ; Ow, S.G.W. ; Lim, J.S.J. ; Chong, W.Q.; Soe, P.P.; Tai, B.C. ; Wang, L. ; Goh, B.C. ; Lee, S.-C. 
41-Mar-2019Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancerSundar, R ; Huang, KK ; Qamra, A; Kim, K-M; Kim, ST; Kang, WK; Tan, ALK; Lee, J; Tan, P 
514-Aug-2020Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.Chong, Wan Qin; Lim, Chwee Ming ; Sinha, Arvind Kumar ; Tan, Chee Seng ; Chan, Gloria Hui Jia; Huang, Yiqing; Barr Kumarakulasinghe, Nesaretnam; Sundar, Raghav ; Jeyasekharan, Anand D ; Loh, Woei Shyang ; Tay, Joshua K. ; Yadav, Kritika ; Wang, Lingzhi ; Wong, Andrea L. ; Kong, Li Ren ; Soo, Ross Andrew ; Lau, Jieying Amelia ; Soon, Yu Yang ; Goh, Robby Miguel; Ho, Francis Cho Hao ; Chong, Siew Meng ; Lee, Soo-Chin ; Loh, Kwok Seng ; Tai, Bee Choo ; Lim, Yaw Chyn ; Goh, Boon Cher 
62017Limb hypothermia for preventing paclitaxel-induced peripheral neuropathy in breast cancer patients: A pilot studySundar, R ; Bandla, A ; Tan, S.S.H ; Liao, L.-D ; Kumarakulasinghe, N.B; Jeyasekharan, A.D ; Ow, S.G.W; Ho, J; Tan, D.S.P; Lim, J.S.J ; Vijayan, J; Therimadasamy, A.K; Hairom, Z; Ang, E; Ang, S; Thakor, N.V ; Lee, S.-C ; Wilder-Smith, E.P.V 
72020Neoadjuvant therapy in locally advanced colon cancer: A meta-analysis and systematic reviewCheong, C.K.; Nistala, K.R.Y.; Ng, C.H.; Syn, N.; Chang, H.S.Y.; Sundar, R. ; Yang, S.Y.; Chong, C.S. 
82020Profiling of gastric cancer cell-surface markers to achieve tumour-normal discriminationToh, J.; Hoppe, M.M. ; Thakur, T. ; Yang, H. ; Tan, K.T. ; Pang, B. ; Ho, S. ; Roy, R. ; Ho, K.Y.; Yeoh, K.G. ; Tan, P. ; Sundar, R. ; Jeyasekharan, A. 
91-Jun-2019Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapyMolassiotis, A.; Cheng, H.L.; Leung, K.T.; Li, Y.C.; Wong, K.H.; Au, J.S.K.; Sundar, R. ; Chan, A. ; Ng, T.R.D.; Suen, L.K.P.; Chan, C.W.; Yorke, J.; Lopez, V. 
101-Nov-2018A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trialsGarces, Alvaro H Ingles; Ang, Joo Ern; Ameratunga, Malaka; Chenard-Poirier, Maxime; Dolling, David; Diamantis, Nikolaos; Seeramreddi, Satyanarayana; Sundar, Raghav ; de Bono, Johann; Lopez, Juanita; Banerji, Udai
111-Sep-2018Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancerBasu, B; Krebs, MG; Sundar, R ; Wilson, RH; Spicer, J; Jones, R; Brada, M; Talbot, DC; Steele, N; Garces, AH Ingles; Brugger, W; Harrington, EA; Evans, J; Hall, E; Tovey, H; de Oliveira, FM; Carreira, S; Swales, K; Ruddle, R; Raynaud, FI; Purchase, B; Dawes, JC; Parmar, M; Turner, AJ; Tunariu, N; Banerjee, S; de Bono, JS; Banerji, U